Clinical Trial Update: Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis [NA]

View source ↗

Summary

This clinical trial evaluated nebulized 3% hypertonic saline for acute bronchiolitis. The study completed with results posted on 2019-01-25.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis

Drugs mentioned

• Hypertonic saline 3% (nebulized) (Hypertonic saline 3%)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Acute Bronchiolitis | NA | Status: COMPLETED | Results posted: 2019-01-25